Overview: Appendix A - Pediatric Antiretroviral Drug Information | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Appendix A: Pediatric Antiretroviral Drug Information

Overview

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors (NRTIs)

Tenofovir alafenamide

Tenofovir disoproxil fumarate

Non-Nucleoside Analogue Reverse Transcriptase Inhibitors (NNRTIs)

Protease Inhibitors (PIs)

Lopinavir/Ritonavir

Entry and Fusion Inhibitors

Capsid Inhibitors

Integrase Inhibitors (INSTIs)

Pharmacokinetic Enhancers

Fixed-Dose Combinations

Appendix A, Table 1. Antiretrovirals Available in Fixed-Dose Combination Tablets or as a Co-packaged Formulation, by Drug Class

Appendix A, Table 2. Antiretroviral Fixed-Dose Combination Tablets: Minimum Body Weights and Considerations for Use in Children and Adolescents

Archived Drugs

Download Guidelines

Section Only PDF (29.05 KB)
Full Guideline PDF (6.12 MB)
Recommendations Only PDF (310.69 KB)
Tables Only PDF (1.17 MB)
Drug Tables Only PDF (2.39 MB)